HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Sign In to gain access to subscriptions and/or personal tools.

This Article Full Text Full Text (PDF) All Versions of this Article: 33/10/1479    most recent 0363546505275010v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Request Reprints Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (15) Citing Articles via Google Scholar Google Scholar Articles by Allen, R. T. Articles by Amiel, D. Search for Related Content PubMed PubMed Citation Articles by Allen, R. T. Articles by Amiel, D. Related Collections Histology Chondral/cartilage

Analysis of Stored Osteochondral Allografts at the Time of Surgical Implantation

R. Todd Allen, MD, PhD^*, Catherine M. Robertson, MD^*, Andrew T. Pennock, MD^*, William D. Bugbee, MD^*, Frederick L. Harwood, MD^*, Van W. Wong, Albert C. Chen, PhD, Robert L. Sah, MD, DSc and David Amiel, PhD^*,

From the ^* Department of Orthopaedic Surgery and the Department of Bioengineering, University of California, San Diego, La Jolla, California

Address correspondence to David Amiel, PhD, University of California, San Diego, Department of Orthopaedic Surgery, 9500 Gilman Drive, Mail Code 0630, La Jolla, CA 92093-0630 (e-mail: fshepherd{at}ucsd.edu; damiel{at}ucsd.edu).

Background: To date, the morphological, biochemical, and biomechanical characteristics of articular cartilage in osteochondral allografts that have been stored have not been fully described.

Hypothesis: Osteochondral allografts procured and stored commercially for a standard period as determined by tissue banking protocol will have compromised chondrocyte viability but preserved extracellular matrix quality.

Study Design: Controlled laboratory study.

Methods: Unused cartilage from 16 consecutive osteochondral allografts was sampled during surgery after tissue bank processing and storage. Ten grafts were examined for cell viability and viable cell density using confocal microscopy, proteoglycan synthesis via ³⁵SO₄ uptake, and glycosaminoglycan content and compared with fresh cadaveric articular cartilage. Biomechanical assessment was performed on the 6 remaining grafts by measuring the indentation stiffness of the cartilage.

Results: The mean storage time for the transplanted specimens was 20.3 ± 2.9 days. Chondrocyte viability, viable cell density, and ³⁵SO₄ uptake were significantly lower in allografts at implantation when compared to fresh, unstored controls, whereas matrix characteristics, specifically glycosaminoglycan content and biomechanical measures, were unchanged. In addition, chondrocyte viability in the stored allografts was preferentially decreased in the superficial zone of cartilage.

Conclusion: Human osteochondral allografts stored for a standard period (approximately 3 weeks) before implantation undergo decreases in cell viability, especially in the critically important superficial zone, as well as in cell density and metabolic activity, whereas matrix and biomechanical characteristics appear conserved. The exact clinical significance of these findings, however, is unknown, as there are no prospective studies examining clinical outcomes using grafts stored for extended periods.

Clinical Relevance: Surgeons who perform this procedure should understand the cartilage characteristics of the graft after 21 days of commercial storage in serum-free media.

Key Words: allograft • osteochondral defect • chondrocyte • confocal microscopy

This article has been cited by other articles:

				S. K. Williams, D. Amiel, S. T. Ball, R. T. Allen, W. L. Tontz Jr, B. C. Emmerson, N. M. Badlani, S. C. Emery, P. Haghighi, and W. D. Bugbee Analysis of Cartilage Tissue on a Cellular Level in Fresh Osteochondral Allograft Retrievals Am. J. Sports Med., December 1, 2007; 35(12): 2022 - 2032. [Abstract] [Full Text] [PDF]

				A. Lightfoot, J. Martin, and A. Amendola Fluorescent Viability Stains Overestimate Chondrocyte Viability in Osteoarticular Allografts Am. J. Sports Med., November 1, 2007; 35(11): 1817 - 1823. [Abstract] [Full Text] [PDF]

				P. A. Davidson, D. W. Rivenburgh, P. E. Dawson, and R. Rozin Clinical, Histologic, and Radiographic Outcomes of Distal Femoral Resurfacing With Hypothermically Stored Osteoarticular Allografts Am. J. Sports Med., July 1, 2007; 35(7): 1082 - 1090. [Abstract] [Full Text] [PDF]

				G. Treme, J. A. Hart, and M. D. Miller What's New in Sports Medicine J. Bone Joint Surg. Am., March 1, 2007; 89(3): 686 - 696. [Full Text] [PDF]

				P. C. McCulloch, R. W. Kang, M. H. Sobhy, J. K. Hayden, and B. J. Cole Prospective Evaluation of Prolonged Fresh Osteochondral Allograft Transplantation of the Femoral Condyle: Minimum 2-Year Follow-Up Am. J. Sports Med., March 1, 2007; 35(3): 411 - 420. [Abstract] [Full Text] [PDF]

				R. E. Glenn Jr, E. C. McCarty, H. G. Potter, S. F. Juliao, J. D. Gordon, and K. P. Spindler Comparison of Fresh Osteochondral Autografts and Allografts: A Canine Model Am. J. Sports Med., July 1, 2006; 34(7): 1084 - 1093. [Abstract] [Full Text] [PDF]

				S. Gortz and W. D. Bugbee Allografts in Articular Cartilage Repair J. Bone Joint Surg. Am., June 1, 2006; 88(6): 1374 - 1384. [Full Text] [PDF]